Pharmafile Logo

EVOKE MIND+MATTER BROADENS STRATEGIC CAPABILITY WITH FULL-SERVICE RESEARCH & INSIGHTS OFFERING

June 17, 2022 |  

Headed up by Research Director, Angela McMean, the Evoke Mind+Matter Insights division comprises a team of primary research specialists focused on delivering meaningful, data-driven insight that supports the agency’s mission to drive measurable behaviour change.

Evoke Mind+Matter has continued to strengthen its integrated marcomms offering with the expansion of its in-house market research capabilities.

Headed up by Research Director, Angela McMean, the Evoke Mind+Matter Insights division comprises a team of primary research specialists focused on delivering meaningful, data-driven insight that supports the agency’s mission to drive measurable behaviour change.

Angela McMean, Research Director at Evoke Mind+Matter said: “Our team of research experts are specialists in research methodologies and data analytics.  We design and deliver bespoke qualitative and quantitativestudies that include patient, healthcare professional and consumer behaviour analysis, social media and sentiment analysis, market understanding, creative concept and message testing, audience segmentation, real world evidence and communications measurement and evaluation.”

The Evoke Mind+Matter insights division sits within the strategy team headed up in the UK by Simon Grist, Strategy & Insights Director.

Simon Grist, UK Strategy & Insights Director at Evoke Mind+Matter said: “We pride ourselves on delivering against our mission to create meaningful experiences that drive meaningful change.  The expansion of our research offering reinforces our commitment to delivering evidence-based strategic programmes built on actionable insights and proven behavioural interventions.”

Evoke Mind+Matter launched a year ago with a fresh, fearless vision of what healthcare communications could be. It closed 2021 with £6m of new business, 200 per cent growth in average client revenue, 60 new hires, months of investment in a new proprietary tech platform (Gravity.ai) and a unique new proposition to create meaningful experiences driven by data and emotion to ultimately change behaviour.

This content was provided by Evoke Mind+Matter

Company Details

 Latest Content from  Evoke Mind+Matter 

Personalized Oncology: Calling for a New Kind of Partnership:

In the 1990s, biomarkers were the future of personalized medicine and a “lab on a chip” was the holy grail of understanding patient health. As much as past predictions of...

EVOKE STRENGTHENS LEADERSHIP TEAM IN EUROPE TO DELIVER MORE INTEGRATED CLIENT SOLUTIONS

*Corrina Safeio, promoted to Group Managing Director taking on responsibility for Evoke London and Evoke Mind+Matter *Lee Wales, promoted to Deputy Managing Director at Evoke Mind+Matter UK *Holly Ford, promoted...

EVOKE MIND+MATTER BOLSTERS SENIOR TEAM WITH TRIO OF STRATEGIC HIRES

*Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen...

EVOKE MIND+MATTER BROADENS STRATEGIC CAPABILITY WITH FULL-SERVICE RESEARCH & INSIGHTS OFFERING

Headed up by Research Director, Angela McMean, the Evoke Mind+Matter Insights division comprises a team of primary research specialists focused on delivering meaningful, data-driven insight that supports the agency’s mission...

MAKING THE FIRST YEAR MATTER

*Mind+Matter closes its first year of business celebrating more than £4 million of new business wins in the UK *The global agency launched in Jan 21 has also been awarded...

ASHFIELD HEALTH LAUNCHES HEALTH INTELLIGENCE PLATFORM, GRAVITY.AI

Dynamic data-driven solution unlocks deeper insights and powers stronger omnichannel experiences.

'Smear Word' campaign for Roche aims to break taboos and save lives

An all-female team at Mind+Matter has created a campaign for Roche that takes a tongue-in-cheek approach to tackle taboos about going for a smear test.

CRYOPORT APPOINTS MIND+MATTER AS PART OF A GLOBAL BRAND DEVELOPMENT TENDER

Cryoport Inc has appointed creative communications agency Mind+Matter, an Ashfield Health company, part of UDG Healthcare as its strategic marketing partner to support the rebrand of the entire business alongside...

Ashfield Healthcare Communications rebrands as Ashfield Health

Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.

A MERGER THAT MATTERS

Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter     ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness   New global agency offers 24/7 access...